Yep they're not going to be doing an offering at these levels and if anything will forego their already planned PODRAS trials and divert that cash towards the CAT 3 HAP studies on Rexista.
As the previous 2 posters already laid out...IPCI mgmt. has lots of available options that don't consist of any need for any offerings at these depressed share price levels glty
Never buy or sell based on my posts! My posts are just my opinion!